In a 13-year-old obese boy with persistent hypertension and acanthosis nigricans, what is the most appropriate initial laboratory test?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 30, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Most Appropriate Initial Laboratory Test

The most appropriate initial laboratory test is fasting glucose and insulin to calculate HOMA-IR (insulin resistance), as this 13-year-old obese boy with acanthosis nigricans most likely has obesity-related hypertension driven by insulin resistance rather than a secondary endocrine cause.

Clinical Reasoning

Why Insulin Resistance Testing is the Answer

This clinical presentation is classic for obesity-related hypertension with insulin resistance:

  • Acanthosis nigricans is a cutaneous marker strongly associated with hyperinsulinemia and insulin resistance 1, 2, 3
  • The combination of obesity + acanthosis nigricans + hypertension forms a metabolic triad that points directly to insulin resistance as the underlying pathophysiology
  • Studies consistently show that obese children with acanthosis nigricans have significantly higher insulin levels, HOMA-IR values, and blood pressure compared to obese children without acanthosis nigricans 1, 2, 3

What the Guidelines Tell Us

The 2017 AAP Pediatric Hypertension Guidelines 4 recommend:

  • Obtaining laboratory studies to evaluate for underlying secondary causes when indicated (Recommendation 15)
  • The guidelines specifically identify obesity as a high-risk condition associated with hypertension
  • History and physical examination should guide the workup for secondary causes

However, the guidelines do NOT recommend routine screening for rare endocrine causes (pheochromocytoma, Cushing's, primary hyperaldosteronism) in obese children with typical features of metabolic syndrome.

Why NOT the Other Options

A. Plasma catecholamines (Pheochromocytoma screening):

  • This patient has no features suggesting pheochromocytoma (no paroxysmal symptoms, headaches, palpitations, sweating episodes)
  • Acanthosis nigricans is NOT associated with pheochromocytoma
  • This would be appropriate for episodic/paroxysmal hypertension with concerning symptoms

B. Plasma renin activity (Primary hyperaldosteronism screening):

  • The guidelines 4 recommend suspecting monogenic hypertension or hyperaldosteronism when there is hypokalemia, suppressed plasma renin, or family history of early-onset hypertension
  • This patient has acanthosis nigricans, which points to insulin resistance, not mineralocorticoid excess
  • No mention of hypokalemia in this case

C. Cortisol (Cushing's syndrome screening):

  • While Cushing's can cause obesity and hypertension, acanthosis nigricans is characteristic of insulin resistance, not hypercortisolism
  • Cushing's typically presents with central obesity, striae, moon facies, and growth deceleration—not the rapid weight gain with acanthosis nigricans seen in metabolic syndrome
  • This would be considered if there were cushingoid features

D. Ambulatory BP monitoring:

  • While ABPM is recommended for high-risk patients with obesity 4, this is a diagnostic tool to confirm hypertension, not a laboratory test to identify the underlying cause
  • The question asks for the most appropriate laboratory test
  • ABPM would be appropriate after confirming persistent hypertension on multiple office visits

The Evidence on Acanthosis Nigricans

Multiple studies demonstrate that acanthosis nigricans in obese children is strongly associated with:

  • Elevated insulin and HOMA-IR (insulin resistance marker) 1, 2, 3
  • Higher blood pressure (both systolic and diastolic) 1, 2
  • Metabolic syndrome features including dyslipidemia 2, 5

Research shows that HOMA-IR ≥3.30 predicts hypertension in obese children with high sensitivity 6, making insulin resistance assessment clinically actionable.

Clinical Pitfalls to Avoid

  • Don't chase zebras: In an obese adolescent with acanthosis nigricans, the hypertension is almost certainly obesity-related, not from a rare endocrine tumor
  • Acanthosis nigricans is the key: This physical finding shifts the probability dramatically toward insulin resistance as the underlying mechanism
  • Cost-effective approach: Starting with insulin resistance testing is more appropriate than expensive and low-yield endocrine tumor workups in this clinical context

Practical Approach

Initial laboratory workup should include:

  • Fasting glucose and insulin (calculate HOMA-IR)
  • Lipid profile (commonly abnormal with insulin resistance) 2
  • Basic metabolic panel (assess for any electrolyte abnormalities)
  • Liver enzymes (assess for fatty liver disease, common in this population) 2, 3

This approach aligns with evaluating the most likely cause (obesity-related hypertension with insulin resistance) rather than rare secondary causes that lack supporting clinical features.

Related Questions

In a 13-year-old obese boy with persistent hypertension, acanthosis nigricans, and symptoms of headache, sweating, and palpitations, what is the next step to establish the diagnosis?
In an 8‑year‑old with progressive daily headaches, new blurry vision and bitemporal peripheral visual field loss, polyuria, nocturnal enuresis, constipation, fatigue, a decline in height percentile, modest weight gain, and diffusely dry skin, which diagnostic test is most likely to provide a definitive diagnosis: dilated funduscopic examination, lumbar puncture with opening pressure measurement, or contrast‑enhanced magnetic resonance imaging (MRI) of the brain?
What are the differential diagnoses for excessive weight gain in a 2‑year‑old child?
What laboratory tests should be ordered for a 17-year-old female with an 8‑lb weight loss over one year, early satiety, and no abdominal pain, diarrhea, or rectal bleeding?
What laboratory tests should be ordered to evaluate a patient with acanthosis nigricans?
In a patient who develops immediate urticaria, angio‑edema, respiratory distress, or gastrointestinal symptoms after shellfish ingestion, what do specific IgE classes 1‑4 represent and how should each class be interpreted regarding the likelihood of true shellfish allergy?
Which supplements or vitamins should be avoided while taking Pristiq (desvenlafaxine)?
In a 38-year-old asymptomatic man with chronic hepatitis B (HBsAg positive, HBeAg positive, anti‑HBc IgG positive) and normal liver enzymes, whose father died of hepatocellular carcinoma at age 60, what is the most appropriate next step in management?
In a 12‑day‑old neonate with non‑bilious vomiting, regurgitation, poor oral intake (~45 mL per feed), normal abdominal ultrasound (no pyloric hypertrophy), normal upper gastrointestinal series showing only gastro‑esophageal reflux, and normal metabolic studies, what is the likely diagnosis, what is the optimal management, and can the nasogastric tube be removed?
Is it safe to give Mobic (meloxicam) 15 mg to a patient on dialysis who has hepatic encephalopathy?
Can an 86-year-old female long-term-care resident taking duloxetine (Cymbalta) 30 mg daily and levetiracetam (Keppra) for seizures be started on valproic acid (Depakote) for mood?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.